Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADMA BIOLOGICS, INC. Director's Dealing 2021

Oct 26, 2021

31261_dirs_2021-10-26_a8d0458e-530e-4677-8b5a-b0f5c76b59f9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADMA BIOLOGICS, INC. (ADMA)
CIK: 0001368514
Period of Report: 2021-10-25

Reporting Person: Grossman Jerrold B (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-25 Common Stock P 100000 $1 Acquired 260864 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 22857 Indirect
Common Stock 31381 Indirect
Common Stock 38294 Indirect
Common Stock 175 Indirect

Footnotes

F1: Represents a purchase from the underwriters in the October 2021 public offering of the issuer.

F2: These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.

F3: These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.

F4: These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.

F5: These shares are owned by the reporting person's wife.